![Helen Torley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Helen Torley
Vorstandsvorsitzender bei
HALOZYME THERAPEUTICS, INC.
Vermögen: 51 Mio $ am 31.05.2026
Profil
Helen I. Torley bekleidet die Position des President, Chief Executive Officer & Director bei Halozyme Therapeutics, Inc. Sie ist auch im Vorstand von Quest Diagnostics, Inc. und Director & Member-Health Section Governing Board bei der Biotechnology Innovation Organization und Mitglied des Royal College of Physicians. In der Vergangenheit war sie Vice President & GM-United States Bone Health bei Amgen, Inc. und Chief Commercial Officer & Executive VP bei Onyx Pharmaceuticals, Inc. (eine Tochtergesellschaft von Amgen, Inc.), Vice President-Medical Affairs bei Novartis, Inc., Vice President-Medical Affairs bei Sandoz SA und Vice President-Cardiovascular & Metabolic Sales bei Bristol-Myers Squibb World Wide Medicines Group. Sie erhielt einen Bachelor-Abschluss von der University of Glasgow.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.06.2026 | 767’780 ( 0.65% ) | 51 Mio $ | 31.05.2026 |
Aktive Positionen von Helen Torley
| Unternehmen | Position | Beginn |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Vorstandsvorsitzender | 06.01.2014 |
| ANTARES PHARMA, INC. | Direktor/Vorstandsmitglied | 24.05.2022 |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Helen Torley
| Unternehmen | Position | Ende |
|---|---|---|
| QUEST DIAGNOSTICS INCORPORATED | Direktor/Vorstandsmitglied | 18.05.2022 |
| RELYPSA INC | Direktor/Vorstandsmitglied | 01.09.2016 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Geschäftsführer | 15.12.2011 |
| AMGEN INC. | Corporate Officer/Principal | 01.01.2011 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.2002 |
Ausbildung von Helen Torley
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
76
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops parenteral pharmaceutical products | Health Technology |
Quest Diagnostics, Inc.
 Quest Diagnostics, Inc. Services to the Health IndustryHealth Services Provides diagnostic testing and information services | Health Services |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
University of Glasgow
 University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Sandoz SA |
